Vivos Therapeutics Inc
NASDAQ:VVOS
Vivos Therapeutics Inc
NASDAQ:VVOS
Price:
2.59 USD
5.28%
Updated:
Apr 29, 2024
Vivos Therapeutics Inc
Cash from Investing Activities
|
Vivos Therapeutics Inc
Cash from Investing Activities Peer Comparison
Comparables:
DVA
DGX
CVS
CI
LH
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Vivos Therapeutics Inc
NASDAQ:VVOS
|
Cash from Investing Activities
-$853k
|
CAGR 3-Years
-92%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
DaVita Inc
NYSE:DVA
|
Cash from Investing Activities
-$771.8m
|
CAGR 3-Years
2%
|
CAGR 5-Years
5%
|
CAGR 10-Years
1%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Cash from Investing Activities
-$1.1B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-21%
|
|
|
CVS Health Corp
NYSE:CVS
|
Cash from Investing Activities
-$20.9B
|
CAGR 3-Years
-56%
|
CAGR 5-Years
14%
|
CAGR 10-Years
-28%
|
|
|
Cigna Corp
NYSE:CI
|
Cash from Investing Activities
-$5.2B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Cash from Investing Activities
-$1.5B
|
CAGR 3-Years
-30%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-14%
|
See Also
What is Vivos Therapeutics Inc's Cash from Investing Activities?
Cash from Investing Activities
-853k
USD
-853k
USD
Based on the financial report for Dec 31, 2023, Vivos Therapeutics Inc's Cash from Investing Activities amounts to -853k USD.
What is Vivos Therapeutics Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
5%
5%
Over the last year, the Cash from Investing Activities growth was 7%. The average annual Cash from Investing Activities growth rates for Vivos Therapeutics Inc have been -92% over the past three years , 5% over the past five years .
You don't have any saved screeners yet
